chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a health care professional on 23 April 2008. A 21 year old, male patient (with no medical history) reported having symptoms of arthritis, nausea, vomited x 1, and malaise, within 24 hours after he received IMOVAX (lot number A0483-4) intramuscularly (site of administration not reported), DECAVAC (lot number U2017BA) intramuscularly (site of administration not reported) and Hep B (Merck, lot number AHBVB452AA) intramuscularly (site of administration not reported) on 16 April 2008. The symptoms cleared within 24 hours and the patient recovered. The patient did not have any illness at the time of the vaccinations and was not on any medications. Follow up information was received from a health care professional on 08 July 2008. The patient received a left deltoid injection of DECAVAC, a right deltoid injection of IMOVAX, and a left leg injection of Hep B. The patient recovered from the events.
Red, bumps/spots, mild rash, on torso, back, neck and thighs no treatment given did not know what to use: doctor did not suggest anything.
Received: 11/5/19, had flu shots before, no allergies to eggs Symptoms (occured after 30mins): redness, itchinessareas: side of stomach & 1 spot in the calf Remedies: she used poison oak Ivy remedy yesterday and it helped with itchiness isolated incident?Possible, pt stated she did pet a dog yesterday (but to her knowledge, no allergies is known to dogs before)My Recommendations: take benedryl & use HC 1%will follow up with her in 2 days to see if she gets better, will notate in system & reference in our adverse reaction database
Ringing in ears that started about 2-3 days after 2nd vaccine dose, 2 weeks at this point, seems worse in L ear.; This is a spontaneous report from a contactable physician (patient). A 44-years-old non-pregnant female received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN5318, expiration date unknown) via unspecified route of administration on arm left at a single dose on 31Jan2021 09:45 (age at the time of vaccination 44-year-old) for COVID-19 immunization. The facility type for vaccine was fire station. The patient had medical history of asthma. Patient had no known allergies. The patient received other medications within 2 weeks of vaccination reported as Beclometasone Dipropionate (QVAR), MVI, Ascorbic Acid (Vit C), Colecalciferol (D3), Melatonin, Diphenhydramine Hydrochloride (Benadryl). The historical vaccination patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3246, expiration date unknown) via unspecified route of administration on arm left at a single dose on 10Jan2021 10:00 for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 02Feb2021 (started about 2-3 days after second dose) patient experienced ringing in ears after second dose. After 2 weeks at this point seems worse in left ear. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the events. The clinical outcome of the event as not recovered. Information on the lot/batch number is captured.
There was not an adverse event- MMR II and Varicella ( varivax)  Patient had already received the following  vaccines on January 3, 2023. Then came back to the office on January 16,2023 & stated he needed another round of the same  vaccines.  CMA administered without checking EMR of the patient.
Dry mouth; Diarrhea; Very weak; Having chills; Throwing up; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), DIARRHOEA (Diarrhea), ASTHENIA (Very weak), CHILLS (Having chills) and VOMITING (Throwing up) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced DRY MOUTH (Dry mouth), DIARRHOEA (Diarrhea), ASTHENIA (Very weak), CHILLS (Having chills), VOMITING (Throwing up) and FATIGUE (Very tired). At the time of the report, DRY MOUTH (Dry mouth), DIARRHOEA (Diarrhea), ASTHENIA (Very weak), CHILLS (Having chills), VOMITING (Throwing up) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications high blood pressure meds No treatment medications provided
Pt developed a cough  with wheezing and shortness of breath day 3 post vaccine. She saw our medical practice for care on day 4 post vaccine. On Wednesday 11/10/21 (day 9 post vaccine) she had a "coughing fit" and lost consciousness. EMS was dispatched and attempted to resuscitate patient but she died shortly there after at the Emergency department.
Patient reported that she started to feel sick the day after she got the shot. Symptoms included fever/chills/muscle aches and lasted 12-24 hours. This did not happen after she got the 1st dose, only the 2nd.
9/17/2022 - pain started in left calf during the night 9/18/2022 - pain in calf continued 9/19/2022- pain continued/ getting worse - went to Urgent Care who encouraged me to go to Emergency for Ultrasound 9/19/2022 - Emergency Room visit - ultra sound of left leg veins - it was observed on the ultra sound I had "slow flow" and they decided to treat it as a DVT. I had blood work up done and was sent home with Eliquis to start taking. They also asked me to follow up with a Vascular Surgeon and have another ultra sound in 2 weeks. 9/21/2022 - followed up with my primary care doctor who also confirmed a blot clot.
Information has been received from a physician concerning a patient who was vaccinated SC with a dose of Zostavax (Oka/Merck).  Subsequently the patient developed a rash that resembled that of shingles.  That patient was treated with valacyclovir HCl (Valtrex).  Unspecified medical attention was sought.  Additional information has been requested.
muscle pain worsened; headache worsened; joint pain; vomiting; lymph node swelling; The caller also got hot and stayed hot for like 2 days. It started after the shot, the caller never ran a fever, it was indescribable/ perceived fevers (but does not have a fever); nausea worsened; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8737) via an unspecified route administered in arm on 17May2021 (at the age of 36-year-old) as Dose 1, Single for covid-19 immunization. The patient's medical history included asthma (diagnosed 3 months ago), water retention (diagnosed 3 years ago). There was no concomitant medications reported. On 17May2021, the patient stated she got hot and stayed hot for like 2 days, it started after the shot, the patient never ran a fever, it was indescribable/ perceived fevers (but does not have a fever) and her nausea worsened. On 18May2021, patient experienced headache worsened, joint pain, vomiting and lymph node swelling and on 19May2021, the patient had muscle pain worsened was reported by patient. No investigation assessment was reported. The outcome of the events was not recovered at the time of reporting.  Follow-up attempts completed. No further information expected.
Administered only the diligent; Administered only the diligent; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 20-FEB-2023 Reporter's Comment:  The reporter reported that the Shingrix vaccine was not mixed and only the diluent was given. The reporter wanted to know guidance on how to proceed. The healthcare professional was disconnected without providing any credentials, patient demographics or vaccine details.  The reporter did not consent to follow up. Additional supportive information: The reporter gave by error Shingrix diluent portion only ,which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 21Jan2021 at 15:00 as dose 1, single (Lot number: EL3249), in left arm, on 11Feb2021 at 14:30 as dose 2, single (Lot number: EM9810), in left arm, on 24Nov2021 at 14:30 as dose 3 (booster), single (Lot number: 33026BD), in left arm and on 04Apr2022 at 15:00 as dose 4 (booster), single (Lot number: FK9895), in left arm for covid-19 immunisation. The patient's relevant medical history included: "mild HTN" (unspecified if ongoing); "osteo arthritis" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL, start date: Feb2018. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (14Jul2022) Positive; (16Jul2022) Negative; (18Jul2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: Paxlovid rebound. Started Rx 06Jul after developing a sore throat and testing positive. Completed Rx 10Jul. Still positive 14Jul, then negative on 16Jul. Sore throat returned again on 17Jul with positive test on the 18th. Symptoms were those of a bad cold. Sore throat>sinus issues>cough. No fever. Shall test again on 23Jul or after symptoms resolve.
pt recv vax 23OCT97 & next AM 8:AM devel extreme soreness & stiffness in arm of inj;pt exp sl redness @ the site;3 days later devel uncontrollable chills that lasted 15min then went away;did not take temp;pain in arm progressed to shoulder;
Pt received vaccines on 6/20/11 in the evening of 6/21/11 leg was warm & red on 6/22/11. Mom states area larger. Cephalexin and BENADRYL prescription given.
Dizziness, off balance, uneven walk 0600 hrs 16 Nov 06. Treatment- stop all medication. Waited till symptoms resided. 0800 hrs 20 Nov 06.
Vaccine recipient received second shot of Pfizer-BioNTech vaccine on 1/4/2021. Reported that starting approximately 24 hours post vaccine developed a low grade fever (99.1), body aches, chills, headache, and malaise. Vaccine recipient took Tylenol. This morning they reported that most of their symptoms have subsided and an occasional headache remains. Pfizer-BioNTech COVID- 19 Vaccine EUA.
1) sore red arm, cellulitis?. 2) Fainting vs seizure the following day.
Hib part of the PENTACEL vaccine was diluted with VAQTA, a Hepatitis A Vaccine (with no reported adverse event); Initial information received on 18-May-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves  patient with unknown demographics and is reported hib part of the diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] was diluted with hepatitis A Vaccine inact [vaqta], a hepatitis A vaccine (with no reported adverse event).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection and Vaqta not produced by Sanofi Pasteur strength, expiry date, lot number not reported via unknown route in unknown administration site for prophylactic vaccination (immunization) and hib part of the pentacel vaccine was diluted with vaqta, a hepatitis A vaccine (with no reported adverse event) (product preparation error) on the same day.Information on the batch number was requested.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event hib part of the pentacel vaccine was diluted with vaqta, a hepatitis a vaccine (with no reported adverse event).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient into clinic 10/15/02, arm red, swollen at injection site. No streaking. Instructed to go to MD if worsens. Patient seen at ER 10/17/02--states golf ball size area at injection site. Area drained and packed at ER.
Bruising at injection site Shingles symptoms started on 12/28/2020, with burning pain on L armpit, progressing with each day, no blisters at time of this report; will be taking acyclovir as per MD consult on 12/20/2020
12/22 Vaccination  4 hours later, chest pain. Felt heavy. Got extremely sleepy. I tried to lay down, episode of syncope. Chest discomfort.  ER for observation
The client had registered as having received 2 doses and was given the Booster in error.
Red eye lids, itchy, inflammation of eye lids. Soreness of arm and skin rash/slight breakout near point of injection on left arm only.
terrible pain you all had; This case was reported by a consumer via interactive digital media and described the occurrence of pain in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter commented that, after reading comments for the terrible pain the all other consumers had, he/she was just going to shut the mouth and push on. The reporter stated the pain other consumers had was much greater. The reporter hoped all other get well and was going to pass this information on to get shingles shots. The follow-up would not possible as no contact details were available. This case has been linked to US2022AMR017842, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR017842:same reporter
6  pm aprox 11/15/21 start of aching in joints, really tired, not much appetite, night sleeping-- headache , mass amount of aching in all joints shoulders, knees, ankles, hands, neck and back. Fever started on 11/16/21 and continued to 11/17/21. The most it was was 2.4 degrees. Better now but still tired and low grade fever as of now .4 over normal. taking Tylenol.
Feels like she is dieing; She did not have a problem with blood pressure before; This spontaneous case was reported by a patient family member or friend and describes the occurrence of FEELING ABNORMAL (Feels like she is dieing) and BLOOD PRESSURE ABNORMAL (She did not have a problem with blood pressure before) in an 8-decade-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feels like she is dieing) and BLOOD PRESSURE ABNORMAL (She did not have a problem with blood pressure before). At the time of the report, FEELING ABNORMAL (Feels like she is dieing) and BLOOD PRESSURE ABNORMAL (She did not have a problem with blood pressure before) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.       No concomitant medication was reported.  It was reported that if the patient did not take the blood pressure medicine exactly correct on time, she felt like she is dying. Patient did not have a problem with blood pressure before.  Treatment information was not provided by the reporter.
16 days post vax devel varicella rash actual pox >20 on abd, neck, arms, back; no fever, maculopapular-vesicular over 3 days period;
One week and a day after receiving the vaccine, I was running an indoor track meet. Following the race (400 meters, masked), I had an intense headache, and then hearing loss in my right ear. The headache went away within minutes; the hearing loss turned out to be permanent.
Approximately 3 hrs after vaccine administration - developed full body aches, chills, malaise.  Next day these symptoms persisted and also developed stomach ache/nausea, fatigue, mild tachycardia, headache, and fever that peaked at 101.7 then broke before going to sleep.  Day 2 post vaccine, continued fatigue and headache as well as sharp stomach pain/cramping.  Day 3 post vaccine, fatigue and headache relieved with Tylenol - mild nausea about half the day before resolving.
Injection site likely improper, right arm pain, very warm at site, increased redness, decreased range of motion right arm
Dizziness, Headache, Arthralgia, chest tightness, sensation of throat swelling, subjective fever, dry mouth, anxiety Narrative:
Wrong Covid Pfizer vaccine given. The 5-11 year one was given instead of the 12 years and up.
7-16-15 Reported by phone to PCP office. Patient took to get checked. 7-16-15. Seen at urgent care-rash lower extremities that is spreading to her arm in the last 24 hr. Platelet count low at 8 cm. Rx prednisone-tapered dose. 7-16-15. Seen at medical center dx: Thrombocytopenia petechiae, idiopathic, thrombocytopenia purpura. CBC-at 10:15-pletelets low - 18 cm. Discharged. 7-17-15 CBC-platelets 52.
On 12/23/20 I noticed some blurred vision in my left eye. My pupil was fixed and dilated, nonreactive. I went to the ER and had a thorough workup-eye exam normal, labs normal, CT head and angiogram normal- the ER doctor along with the neurologist and ophthalmologist diagnosed me with Adie's pupil. I had a follow up eye doctor appointment 12/29/20. I still have a little blurred vision but improving and my pupils are almost and same size and my left eye is reactive to light. Everything else with my eye exam was normal. All the doctors I saw were not sure if the vaccine could have contributed to Adie's pupil.  Not sure if it is related - with my work up there were no other indications of what could have caused this.  to item 20- I am recovering from Adie's pupil- everything is improved but I still have some blurred vision. Pupil size is almost normal and my left pupil reacts normally to light.
Noticed itching upper back middle to right side (over shoulder blade) approx  11 hours after injection.  Approx 3 hr later woke up itching on left and right side.   Left more than right.   Turned on the light and noticed small red bumps.   She applied aloe vera gel and returned to bed.   When she woke in the morning.  Reapplied aloe gel,  the bumps were almost all gone by mid afternoon and no further itching.
pt recv vax 15DEC95 & LMP 7DEC95;15JAN96 urine test positive for pregnancy;ultrasounds 24JAN96 & 6FEB96 revealed sac bleed;22FEB96 pt devel sinus infect tx w/meds;3APR96 pt devel UTI tx w/meds;28FEB96 ultrasound revealed bleeding around sac
Chills Diarrhea Headaches Body Aches Mailaise Confusion Fatigue
Patient experienced shortness of breath and leg cramps, went to urgent care for a work up. per patient the tests were negative for anything remarkable .
Complained of scratchy throat and frequent coughing 15 minutes after administering vaccine. Has blotchy red areas on right arm. No laryngeal edema, swelling of lips or tongue, or difficulty breathing. Lungs clear. Given 50 mg of BENADRYL PO. Relief of symptoms reported within 20 minutes of administering BENADRYL.
Within 1 week, noted numbness and tingling in armpit and middle and ring finger left arm. Within 6 weeks, noted increase of weakness of lower left arm and weak left hand grasp. Occasional dropping of objects placed in left hand. Today, he feels some return of strength. Occaionally notices numbness and tingling of left armpit and fingers.  Follow up 06/05/2000: "Patient partially recovered from adverse event.  Numbness underarm in armpit area and numbness of ring finger some improvement in strength and grip."
Numbness to left ear lobe, down to left side neck, left arm. Asked the nurse to evaluate him. Dr. quoted hr was in 70's. Had EMT come over to check bp. systolic 150-170  diastolic 110/130. hr steady. went home bp went down. Took shower, bp went down 120's - 130's over 70's-80's. concerned about the tingling and went to pcp for numbness to left side of face. CXR was done. Had labs done. no results back yet. Yesterday started feeling joint, back pain, feeling run down. scheduled for T bubble study next year. Still feel run down mildly but numbness and tingling still remains.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 17-MAR-2015, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 26-SEP-2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Patient received Moderna vaccines 4/13 and 5/11/2021.  On 11/9-11/16/2021, patient was admitted to hospital with strokes.  TEE showing clot on Mitral valve.  Initial blood cultures negative.  HIV negative.  Patient was discharged to home on Lovenox.  Patient on 11/22 admitted with additional strokes, presumably cardioembolic from the clot on her mitral valve.  On 11/25 she was evaluated by cardiac surgeon who deemed patient too unstable to undergo surgery.  Emperic antibiotic started 11/25 and her repeat blood cultures (11/25 and 11/28) as well as her initial blood culture remained negative.  Patient continued to experience debilitating strokes and she was made comfort care.  Patient expired 11/29/2021.